SPY304.49+1.52 0.50%
DIA254.45+0.10 0.04%
IXIC9,489.87+120.88 1.29%

Oppenheimer Maintains Outperform on Novavax, Raises Price Target to $38.5

Oppenheimer maintains Novavax (NASDAQ:NVAX) with a Outperform and raises the price target from $19 to $38.5.

Benzinga · 05/12/2020 12:18

Oppenheimer maintains Novavax (NASDAQ:NVAX) with a Outperform and raises the price target from $19 to $38.5.